A curated ncRNAomics knowledgebase for bridging basic and clinical research in eye diseases.

Detail of hsa-miR-210
ncRNA name hsa-miR-210
ncRNA Category miRNA
Disease name von Hippel-Lindau disease
Species Homo sapiens
Tissues/Cell_line blood
Methods qRT-PCR
Expression pattern associated
Functional description Mir210 is a micro-RNA responsive to hypoxia that we have used as a new putative biomarker to follow VHL patient evolution during the clinical trial.
PubMed ID 28662711
Year 2017
Title Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Drug-related ncRNA NO

Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.